The Stochastic Oscillator for BMI moved out of overbought territory on November 09, 2026. This could be a bearish sign for the stock and investors may want to consider selling or taking a defensive position. A.I.dvisor looked at 63 similar instances where the indicator exited the overbought zone. In 42 of the 63 cases the stock moved lower. This puts the odds of a downward move at 67%.
The 10-day RSI Indicator for BMI moved out of overbought territory on November 05, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 30 similar instances where the indicator moved out of overbought territory. In 18 of the 30 cases, the stock moved lower in the following days. This puts the odds of a move lower at 60%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where BMI declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 58%.
BMI broke above its upper Bollinger Band on October 22, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Momentum Indicator moved above the 0 level on October 19, 2026. You may want to consider a long position or call options on BMI as a result. In 60 of 94 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 64%.
The Moving Average Convergence Divergence (MACD) for BMI just turned positive on October 09, 2026. Looking at past instances where BMI's MACD turned positive, the stock continued to rise in 28 of 46 cases over the following month. The odds of a continued upward trend are 61%.
BMI moved above its 50-day moving average on October 21, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for BMI crossed bullishly above the 50-day moving average on October 22, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 10 of 18 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 56%.
Following a +4.22% 3-day Advance, the price is estimated to grow further. Considering data from situations where BMI advanced for three days, in 184 of 306 cases, the price rose further within the following month. The odds of a continued upward trend are 60%.
The Aroon Indicator entered an Uptrend today. In 110 of 211 cases where BMI Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 52%.
The Tickeron Price Growth Rating for this company is 39 (best 1 - 100 worst), indicating steady price growth. BMI’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 49 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron PE Growth Rating for this company is 56 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 70 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BMI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 81, placing this stock better than average.
The Tickeron Valuation Rating of 82 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.714) is normal, around the industry mean (1.448). P/E Ratio (36.786) is within average values for comparable stocks, (5.350). Projected Growth (PEG Ratio) (2.931) is also within normal values, averaging (5.470). Dividend Yield (0.011) settles around the average of (0.012) among similar stocks. P/S Ratio (4.255) is also within normal values, averaging (32.028).
NOVT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 32 of 43 cases where NOVT's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 74%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 44 of 64 cases where NOVT's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 69%.
The 10-day moving average for NOVT crossed bullishly above the 50-day moving average on October 30, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 11 of 19 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 58%.
Following a +10.74% 3-day Advance, the price is estimated to grow further. Considering data from situations where NOVT advanced for three days, in 195 of 300 cases, the price rose further within the following month. The odds of a continued upward trend are 65%.
The Momentum Indicator moved below the 0 level on November 10, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on NOVT as a result. In 74 of 97 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 76%.
The Moving Average Convergence Divergence Histogram (MACD) for NOVT turned negative on November 05, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 55 similar instances when the indicator turned negative. In 36 of the 55 cases the stock turned lower in the days that followed. This puts the odds of success at 65%.
NOVT moved below its 50-day moving average on November 10, 2026 date and that indicates a change from an upward trend to a downward trend.
The 50-day moving average for NOVT moved below the 200-day moving average on November 05, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where NOVT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 69%.
The Tickeron PE Growth Rating for this company is 22 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 51 (best 1 - 100 worst), indicating steady price growth. NOVT’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 83 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 96 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.162) is normal, around the industry mean (1.448). P/E Ratio (85.000) is within average values for comparable stocks, (5.350). NOVT's Projected Growth (PEG Ratio) (23.270) is slightly higher than the industry average of (5.470). Dividend Yield (0.000) settles around the average of (0.012) among similar stocks. P/S Ratio (5.043) is also within normal values, averaging (32.028).
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NOVT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 81, placing this stock worse than average.
BMI | NOVT | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 22 | 36 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 82 Overvalued | 96 Overvalued | |
PROFIT vs RISK RATING 1..100 | 70 | 100 | |
SMR RATING 1..100 | 49 | 83 | |
PRICE GROWTH RATING 1..100 | 39 | 51 | |
P/E GROWTH RATING 1..100 | 56 | 22 | |
SEASONALITY SCORE 1..100 | 50 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
BMI's Valuation (82) in the Electronic Equipment Or Instruments industry is in the same range as NOVT (96). This means that BMI’s stock grew similarly to NOVT’s over the last 12 months.
BMI's Profit vs Risk Rating (70) in the Electronic Equipment Or Instruments industry is in the same range as NOVT (100). This means that BMI’s stock grew similarly to NOVT’s over the last 12 months.
BMI's SMR Rating (49) in the Electronic Equipment Or Instruments industry is somewhat better than the same rating for NOVT (83). This means that BMI’s stock grew somewhat faster than NOVT’s over the last 12 months.
BMI's Price Growth Rating (39) in the Electronic Equipment Or Instruments industry is in the same range as NOVT (51). This means that BMI’s stock grew similarly to NOVT’s over the last 12 months.
NOVT's P/E Growth Rating (22) in the Electronic Equipment Or Instruments industry is somewhat better than the same rating for BMI (56). This means that NOVT’s stock grew somewhat faster than BMI’s over the last 12 months.
| BMI | NOVT | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 60% | N/A |
| Stochastic ODDS (%) | 2 days ago 67% | 2 days ago 69% |
| Momentum ODDS (%) | 2 days ago 64% | 2 days ago 76% |
| MACD ODDS (%) | 2 days ago 61% | 2 days ago 65% |
| TrendWeek ODDS (%) | 2 days ago 62% | 2 days ago 71% |
| TrendMonth ODDS (%) | 2 days ago 62% | 2 days ago 72% |
| Advances ODDS (%) | 17 days ago 60% | 3 days ago 65% |
| Declines ODDS (%) | 6 days ago 58% | 7 days ago 69% |
| BollingerBands ODDS (%) | 2 days ago 52% | 2 days ago 74% |
| Aroon ODDS (%) | 2 days ago 52% | N/A |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
BMI’s FA Score shows that 0 FA rating(s) are green while NOVT’s FA Score has 1 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
BMI’s TA Score shows that 6 TA indicator(s) are bullish while NOVT’s TA Score has 4 bullish TA indicator(s).
BMI (@Electronic Equipment/Instruments) experienced а +3.28% price change this week, while NOVT (@Electronic Equipment/Instruments) price change was -16.12% for the same time period.
The average weekly price growth across all stocks in the @Electronic Equipment/Instruments industry was -0.89%. For the same industry, the average monthly price growth was -11.03%, and the average quarterly price growth was -15.84%.
BMI is expected to report earnings on Jan 22, 2027.
NOVT is expected to report earnings on Mar 02, 2027.
This industry manufactures electronic products used in various critical and sophisticated technologies, including laser-based systems, circuit and continuity testers, electro-optical measuring instruments and high-speed precision weighing and inspection equipment. Some major companies operating in this business are Canon Inc., Keysight Technologies Inc., and Fortive Corp.
A.I.dvisor indicates that over the last year, BMI has been loosely correlated with BKSY. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if BMI jumps, then BKSY could also see price increases.
| Ticker / NAME | Correlation To BMI | 1D Price Change % | ||
|---|---|---|---|---|
| BMI | 100% | -1.01% | ||
| BKSY - BMI | 33% Loosely correlated | -0.25% | ||
| ARBE - BMI | 28% Poorly correlated | -0.64% | ||
| NOVT - BMI | 27% Poorly correlated | -15.26% | ||
| VNT - BMI | 24% Poorly correlated | -1.71% | ||
| TRMB - BMI | 23% Poorly correlated | +0.13% | ||
More | ||||
A.I.dvisor indicates that over the last year, NOVT has been loosely correlated with ST. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if NOVT jumps, then ST could also see price increases.
| Ticker / NAME | Correlation To NOVT | 1D Price Change % | ||
|---|---|---|---|---|
| NOVT | 100% | -15.26% | ||
| ST - NOVT | 52% Loosely correlated | -0.40% | ||
| VPG - NOVT | 51% Loosely correlated | +1.29% | ||
| BKSY - NOVT | 40% Loosely correlated | -0.25% | ||
| CGNX - NOVT | 39% Loosely correlated | +0.91% | ||
| ITRN - NOVT | 39% Loosely correlated | -4.21% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| DAT | 53.62 | N/A | N/A |
| ProShares Big Data Refiners ETF (DAT) | |||
| XSPI | 47.30 | -0.10 | -0.21% |
| NEOS Boosted S&P 500 High Income ETF (XSPI) | |||
| GYLD | 13.25 | -0.07 | -0.56% |
| Arrow Dow Jones Global Yield ETF (GYLD) | |||
| CGNG | 33.32 | -0.20 | -0.60% |
| Capital Group New Geography Equity ETF (CGNG) | |||
| TECB | 73.38 | -0.56 | -0.76% |
| iShares U.S. Tech Breakthrough Multisector ETF (TECB) | |||